Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicure (MCUJF) EBITDA (2016 - 2025)

Historic EBITDA for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to $751154.4.

  • Medicure's EBITDA rose 15681.52% to $751154.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $471324.1, marking a year-over-year decrease of 7719.93%. This contributed to the annual value of $491072.5 for FY2024, which is 5398.84% down from last year.
  • As of Q3 2025, Medicure's EBITDA stood at $751154.4, which was up 15681.52% from -$1.3 million recorded in Q2 2025.
  • Medicure's 5-year EBITDA high stood at $4.0 million for Q4 2022, and its period low was -$1.3 million during Q2 2025.
  • Over the past 5 years, Medicure's median EBITDA value was $501082.9 (recorded in 2025), while the average stood at $647801.0.
  • Per our database at Business Quant, Medicure's EBITDA soared by 493738.8% in 2021 and then crashed by 27856.29% in 2025.
  • Medicure's EBITDA (Quarter) stood at $2.5 million in 2021, then soared by 59.5% to $4.0 million in 2022, then plummeted by 84.16% to $631700.5 in 2023, then fell by 15.92% to $531160.1 in 2024, then surged by 41.42% to $751154.4 in 2025.
  • Its EBITDA stands at $751154.4 for Q3 2025, versus -$1.3 million for Q2 2025 and $501082.9 for Q1 2025.